← Open Payments lookup

SHEILA SPEARS: Open Payments

NPI 1447711833 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$768 in 37 payments from 15 companies in 2025. Trend: 2023 $93 · 2024 $595 · 2025 $768

Food & beverage: $768
CompanyPaymentsAmount
Gilead Sciences, Inc.4$137
Boehringer Ingelheim Pharmaceuticals, Inc.6$110
RECORDATI_RARE_DISEASES_INC.1$97
ABBVIE INC.4$85
Novo Nordisk Inc5$76
Dexcom, Inc.3$57
Bayer Healthcare Pharmaceuticals Inc.2$34
Phathom Pharmaceuticals, Inc.4$33
AstraZeneca Pharmaceuticals LP2$32
Alnylam Pharmaceuticals Inc.1$21

Products named: JARDIANCE, Epclusa, PANHEMATIN, Dexcom G6 Transmitter, VRAYLAR, Ozempic, Kerendia, VOQUEZNA.

Industry payments across TX — which companies pay providers there.